Dr. K. Kiran Kumar-Radiation Oncologist in Hyderabad

Dr. K. Kiran Kumar


Radiation Oncologist

  • Radiation Oncologist
  • MBBS - Dr. NTR University of Health Sciences Andhra Pradesh - 2001
  • MD - Radiotherapy - Nizam Institute of Medical Sciences, Hyderabad - 2006
  • DNB - Radiotherapy - National Board Of Examination - 2011
  • Registrar Yashoda Hospital - 2007 - 2008
  • Consultant Radiation Oncologist Yashoda Hospitals - 2008 - Currently Working
  • 46981 Andhra Pradesh Medical Council 2002
Awards and Recognitions
  • Research and Articles :
  • Principal investigator in Trial no 1200.161 - Trial title - A randomized- open-label- phase III study to evaluate the efficacy and safety of oral afatinib versus intravenous methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy
  • Principal investigator trial numbers:1200:131 Trial title:LUX-Head and Neck 2:randomised- double blind- placebo-controlled- phase III study to evaluate the efficacy and safety of afatinib as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III- IVa- or IVb loco-regionally advanced head and neck squamous cell carcinoma
  • Title: P276-00/64/11 ?A Multicenter- Phase II/III study to assess radiation induced mucositis in subjects with locally advanced squamous cell carcinoma of the head and neck- administered cisplatin and radiation with or without P276-00
  • Title NETU08-18: A phase III multicenter- randomized- double-blind- double-dummy-a ctive-controlled- parallel group study of the efficacy and safety of oral netupitant administered in combination with palonosetron and dexamethasone compared to oral palonosetron and dexamethasone for the prevention of nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
  • Title:PALO10-01:Single dose- multicenter- randomized- double-blind- double-dummy-parallel group study to assess the efficacy and safety of oral palonosetron 0.50 mg compared to I.V palonosetron 0.25mg administered with dexamthasone for the prevention of chemotherapy- induced nausea and vomiting in cancer patients receiving highly emetogenic cisplatin - based chemotherapy
  • Member - Association of Radiation Oncologist of India
  • Member - Indian Medical Association
  • ESMO
  • ARIO

Report an error

Practice Location


Rajbhavan Road

Matha Nagar

Opp Adp Office

Somajiguda , Hyderabad

Fee : ₹ 550


Get direction


OP Timings

Mon - Sat 10:00 am - 05:00 pm
No Reviews Found!
Write a review for Dr. K. Kiran Kumar

Which clinic or hospital you visited

I Recommend this Doctor for

Write your experience aboutDr. K. Kiran Kumar